Mindfulness-Based Stress Reduction for Mothers with Preterm Infants
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Mindfulness-Based Stress Reduction with Self-Compassion (MBSC) for mothers with preterm infants?
Research shows that Mindfulness-Based Stress Reduction (MBSR) can help mothers of premature infants by increasing their posttraumatic growth, which means they experience positive changes after stressful events. This suggests that similar mindfulness-based treatments, like MBSC, could also be beneficial for reducing stress and improving mental health in these mothers.12345
Is Mindfulness-Based Stress Reduction safe for mothers with preterm infants?
How is the treatment Mindfulness-Based Self-Compassion (MBSC) unique for mothers with preterm infants?
Mindfulness-Based Self-Compassion (MBSC) is unique because it combines mindfulness (being present and aware) with self-compassion (being kind to oneself), which can help mothers of preterm infants reduce stress and promote personal growth. Unlike other treatments, MBSC specifically targets the emotional well-being of mothers, potentially improving their ability to cope with the challenges of having a baby in the NICU.123910
What is the purpose of this trial?
The overarching purpose of this study is to determine if a modified 8-week mindfulness-based intervention (with a focus on self-compassion; MBSC) or 8 weeks of 2000 IU vitamin D supplementation will reduce stress and increase self-compassion in mothers of preterm infants and beneficially modify the human milk produced, and subsequently improve infant health.
Research Team
Yimin Chen, PhD
Principal Investigator
University of Idaho
Eligibility Criteria
This trial is for mothers of preterm infants born before 36 weeks gestation at Oregon Health and Sciences University. It's designed to help those experiencing stress postpartum, aiming to improve both maternal mental health and infant outcomes.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized into control, mindfulness intervention, or vitamin D supplementation groups for 8 weeks
Follow-up
Participants are monitored for changes in stress, self-compassion, and human milk composition
Treatment Details
Interventions
- MBSC
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Idaho
Lead Sponsor
Oregon Health and Science University
Collaborator
National Institute of General Medical Sciences (NIGMS)
Collaborator
Oregon State University
Collaborator
Kootenai Health
Collaborator